Esperion Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Great. Good afternoon, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing the 44th Annual Healthcare Conference today with Esperion. So first, you're going to hear a presentation from the company, and then we're going to have a Q&A session after that. So for everyone in the room, when you have a question, just raise your hand so someone can bring you a microphone for the webcast. And if you're listening online, you can submit questions on the portal. I can ask them up here.
So with that, let me pass it over to Esperion's CEO, Sheldon Koenig.
Great. Thank you, Jess, and good afternoon, everyone. On behalf of Esperion and all the employees that work there, it's always a privilege to be here at the JPMorgan Conference and really appreciate the time to talk about our Vision 2040. And really, what it's about is executing today while building for tomorrow. So what has got us here,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
